Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | JUN | P05412 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | WNT3A | P56704 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7093856 | 0.88 | PTGDR2 (0.33) | PTGDR2PTGS1PTGS2CYP2C9CES2 | |
| SCHEMBL6270480 | 0.88 | PTGS1 (0.38) | PTGDR2PTGS1PTGS2CES2PIM1 | |
| SCHEMBL6557433 | 0.87 | ALDH1A1 (0.33) | PTGDR2PTGS1PTGS2CES2PIM1 | |
| SCHEMBL8312959 | 0.84 | KDM4E (0.35) | CYP2C9KDM4EALDH1A1 | |
| SCHEMBL7094132 | 0.84 | CFTR (0.41) | PTGDR2CYP2C9KDM4EALDH1A1HPGD | |
| SCHEMBL7093857 | 0.83 | CHRM1 (0.33) | PTGDR2PTGS1PTGS2 | |
| SCHEMBL6268789 | 0.82 | HIF1A (0.36) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL7091070 | 0.80 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL8897866 | 0.80 | PTGS1 (0.37) | PTGDR2PTGS1PTGS2CES2PIM1 | |
| SCHEMBL8315164 | 0.79 | CTSL (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1283207-B1 | Process for producing benzopyran carboxamide | CENTRAL GLASS CO LTD (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-6653488-B2 | Reacting a 3-aminopropionitrile with benzophenonecarboxylic acid; amidation | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-11-25 | — | — | US | disclosed |
| US-20030065197-A1 | Process for producing benzopyran carboxamide | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-1283207-A1 | Process for producing benzopyran carboxamide | Central Glass Company, Limited (JP) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065197-A1 | Process for producing benzopyran carboxamide | NCDN, CTH, PFAS | PTGDR2 3482/4885PTGS1 3018/4885PTGS2 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.